207 related articles for article (PubMed ID: 37249929)
1. Effect of Flexible Half-Dose Gonadotropin-Releasing Hormone Antagonist Protocol on in vitro Fertilization Outcome in Predicted Normal Responder: A Study Protocol for a Multicentered, Randomized, Non-Inferiority, Parallel Controlled Trial.
Ma YJ; Li MY; Song JY; Sun ZG
Drug Des Devel Ther; 2023; 17():1557-1566. PubMed ID: 37249929
[TBL] [Abstract][Full Text] [Related]
2. Impact of growth hormone on IVF/ICSI outcomes and endometrial receptivity of patients undergoing GnRH antagonist protocol with fresh embryo transfer: a pilot study.
Chu Y; Wang L; Xie J; Yang S; Liu S; Hu D; Yue J
Front Endocrinol (Lausanne); 2023; 14():1225121. PubMed ID: 37727454
[TBL] [Abstract][Full Text] [Related]
3. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
[TBL] [Abstract][Full Text] [Related]
4. Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial.
Ye H; Shi L; Quan X; Hou M; Ma H; Xue S; Yu Z; Chen Q; Sun L
Hum Fertil (Camb); 2024 Dec; 27(1):2316005. PubMed ID: 38357937
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone-based modified GnRH antagonist protocol in normal responders undergoing
Liu S; Lv Y; Liu M; Han S; Liu X; Zhao Z; Cui W; Yang A; Li Y
Front Endocrinol (Lausanne); 2022; 13():922950. PubMed ID: 36034460
[TBL] [Abstract][Full Text] [Related]
7. Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study.
Zhao Y; Lian F; Xiang S; Yu Y; Pang C; Qiu Y
BMC Pregnancy Childbirth; 2021 Oct; 21(1):727. PubMed ID: 34706665
[TBL] [Abstract][Full Text] [Related]
8. A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial.
Liu S; Lv YS; Han S; Liu M; Ma S; Ren H; Li Y
Trials; 2022 Aug; 23(1):654. PubMed ID: 35964041
[TBL] [Abstract][Full Text] [Related]
9. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
10. A premature luteinizing hormone surge without elevated progesterone levels has no adverse effect on cumulative live birth rate in patient undergoing a flexible GnRH antagonist protocol: a retrospective study.
Zhang Y; Xu Y; Yu J; Wang X; Xue Q; Shang J; Yang X; Shan X
J Ovarian Res; 2023 Jun; 16(1):119. PubMed ID: 37370146
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial.
Zhang Y; Liu L; Qin J; Huang H; Xue L; Wang S; Tan W
Reprod Biol Endocrinol; 2021 Oct; 19(1):158. PubMed ID: 34641897
[TBL] [Abstract][Full Text] [Related]
12. Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis.
Liu C; Tian T; Lou Y; Li J; Liu P; Li R; Qiao J; Wang Y; Yang R
Expert Rev Mol Med; 2023 Dec; 26():e2. PubMed ID: 38095077
[TBL] [Abstract][Full Text] [Related]
13. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.
Yang J; Zhang X; Ding X; Wang Y; Huang G; Ye H
Reprod Biol Endocrinol; 2021 Aug; 19(1):124. PubMed ID: 34384445
[TBL] [Abstract][Full Text] [Related]
14. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
Kadoura S; Alhalabi M; Nattouf AH
Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
[TBL] [Abstract][Full Text] [Related]
15. Luteinising hormone-based protocol versus traditional flexible gonadotropin-releasing hormone antagonist protocol in women with normal ovarian response: study protocol for a non-inferiority trial.
Lv YS; Li Y; Liu S
BMJ Open; 2021 Aug; 11(8):e047974. PubMed ID: 34408042
[TBL] [Abstract][Full Text] [Related]
16. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
[TBL] [Abstract][Full Text] [Related]
17. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
[TBL] [Abstract][Full Text] [Related]
18. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
[TBL] [Abstract][Full Text] [Related]
19. Comparison of progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in terms of preventing premature LH surge and assisted reproductive technology outcome in infertile women: a randomized controlled trial.
Jabarpour M; Pouri S; Aleyasin A; Shabani Nashtaei M; Najafian A
Arch Gynecol Obstet; 2024 May; 309(5):1999-2008. PubMed ID: 38421423
[TBL] [Abstract][Full Text] [Related]
20. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
